Capital Guardian Trust’s Core Laboratories CLB Stock Holding History

Capital Guardian Trust’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-33	Closed	-$2K	–	246
2019 Q1	$2K	Sell	33 -17	-34%	-$1.14K	﹤0.01%	298
2018 Q4	$3K	Sell	50 -62	-55%	-$5.35K	﹤0.01%	259
2018 Q3	$13K	Buy	+112	New	+$12.6K	﹤0.01%	446
2017 Q4	–	Sell	-69,000	Closed	-$6.81M	–	227
2017 Q3	$6.81M	Sell	69,000 -1,011	-1%	-$98K	0.12%	130
2017 Q2	$7.09M	Sell	70,011 -17,000	-20%	-$1.83M	0.13%	130
2017 Q1	$10.1M	Sell	87,011 -32,000	-27%	-$3.72M	0.08%	171
2016 Q4	$14.3M	Buy	+119,011	New	+$13.2M	0.11%	150

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Guardian Trust's CLB Position: Q2 2019 in Review

Capital Guardian Trust sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 33 shares — an estimated $2K sold.

Capital Guardian Trust first reported a position in CLB in Q4 2016 and held it in 7 quarters. The position peaked at $14.3M in Q4 2016. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Capital Guardian Trust reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Capital Guardian Trust sold 33 Core Laboratories shares in Q2 2019, an estimated $2K.
Capital Guardian Trust first reported a position in Core Laboratories in Q4 2016 and held it in 7 quarters.
Capital Guardian Trust's Core Laboratories position peaked at $14.3M in Q4 2016.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.